Iyada oo xaddidan ama aan lahayn waxqabadyo ka baxsan manhajka muddo dheer, go'doomin, iyo xidhidhyo dugsi labadii sano ee la soo dhaafay, da'yarta Mareykanka iyo dhalinyarada qaangaarka ah waxaa laga helay tiro aan horay loo arag oo cudurrada caafimaadka maskaxda ah ka hor iyo inta uu ku dhex jiro cudurka faafa ee COVID-19. .
Doorashada dawada saxda ah ee lagu daweynayo xaaladahan waxay noqon kartaa mid adag maadaama qof walba jidhkiisa iyo is-qurxintu ay kala duwan yihiin. Sababtoo ah habka loo helo daawada saxda ah waxay noqon kartaa mid xanuun badan, niyadjab leh, iyo waqti lumis, dhakhaatiirtu waxay u baahan yihiin qalab si ay u go'aamiyaan daawooyinka iyo qiyaasta ugu fiican ee lagu xakameynayo xaaladaha dhimirka sida niyad-jabka, walaaca, iyo ADHD iyo sidoo kale xaalado kale oo caafimaad. Helitaanka daawada saxda ah waxay sidoo kale noqon kartaa khatar maadaama ku dhawaad boqolkiiba shan dhimashada Mareykanka ay sabab u tahay sunta daroogada.
Shaybaarada GENETWORx waxay caddeeyeen farqigan adeegyada daryeelka caafimaadka ilaa 2013 waxayna bilaabeen inay farqigaas ku soo daraan baarista farmashiyaha ama PGx ee ka caawiya dhakhaatiirta inay helaan daawooyinka saxda ah iyo qiyaasta saxda ah markii ugu horeysay ee ku saleysan DNA-da bukaanka.
Sidoo kale loogu yeero "daawa shakhsi ahaaneed," Tijaabada PGx hadda waxay ku jirtaa iftiinka iyada oo la raacayo sharci dhawaan lagu soo bandhigay Aqalka Wakiilada ee Maraykanka oo loo yaqaan 'The Right Drug Right Dose Now Act' kaas oo doonaya in la dardargeliyo waxbarashada iyo isticmaalka pharmacogenetic (PGx) baaritaanka si looga caawiyo ka hortagga dhibaatooyinka. falcelinta daroogada iyo in la fududeeyo is dhexgalka macluumaadka genomic ee la xiriira jawaabta daroogada ee daryeelka bukaanka.
"Iyadoo aan la ogeyn daawadu waxay noqon doontaa doorashada ugu fiican ee bukaanka la siiyey, waxay noqon kartaa tijaabo iyo qalad dhakhtarka - waxay soo qaataan daawo ku salaysan waayo-aragnimadoodii hore ama macluumaadka qorista daroogada iyagoo rajaynaya in jidhka bukaanku si wax ku ool ah uga jawaabo. Daawooyinka shakhsi ahaaneed ee loo isticmaalo baaritaanka PGx iyada oo lala kaashanayo qalabyada kale ee lagu ogaanayo waxay qaadataa inta badan qiyaasaha waxtarka daawada, "ayuu yiri Dr. Stacey Blankenship, PharmD., ee GENETWORx Laboratories.
Sida laga soo xigtay Dr. Blankenship, ogaanshaha qurxinta hidde ee qofka iyada oo loo marayo baaritaanka PGx waxay caawisaa in la aqoonsado dawooyinka jidhku burburiyo oo dheef-shiid kiimikaado. Dheef-shiid kiimikaad ee daawadu waxay ku yeelan kartaa cawaaqib xumo saameynteeda daawaynta ama sunteeda. Tusaale ahaan, bal in dawada jidhku si degdeg ah u dheefshiido ama si tartiib tartiib ah u noqon doonto mid waxtar leh,” ayay tidhi.
Sida laga soo xigtay machadyada Qaranka ee dhawaan daraasadda caafimaadka, baaritaanka farmashiyaha "ayaa awood u leh inuu hoos u dhigo cudurrada, hoos u dhigo daaweynta-waxyeellooyinka degdega ah, hagaajinta jawaabta daaweynta, hoos u dhigista bukaan-jiifka iyo dib-u-kicinta sababtoo ah la'aanta waxtarka ama saameynaha, iyo kharashka daryeelka bukaanka iyo qoyskiisa ama keeda.
Tijaabada PGx waa mid aan fiicneyn iyadoo la isticmaalayo suuf fudud oo dhabanka bukaanka ah. Waxaa ka faa'iidaysan kara bukaan kasta oo qaata dawooyinka cudurrada dhimirka iyo caafimaadka labadaba. Dhakhaatiirtu waxay isticmaalayaan baaritaanka GENETWORx PGx si ay ugu wargeliyaan go'aanadooda daawadooda ee bukaanada loo qorsheeyay qaliinka, bukaanada gabowga ee dawooyinka kala duwan ee xarumaha nolosha la caawiyay, iyo cuduro kale oo badan oo caafimaad iyo sidoo kale ogaanshaha caafimaadka dabeecadda. Intaa waxaa dheer, Medicare wuxuu dabooli karaa baaritaanka xaalado badan sida caymisyo badan oo gaar ah.
"Runtii waa qalab aan caadi ahayn oo siinaya bixiyaha iyo bukaanka kalsooni dheeraad ah in daawadii saxda ahayd la doortay markii ugu horeysay," ayuu yiri Blankenship.
MAXAA LAGU QAADAYAA MAQAALKAN:
- “Without knowing which medication will be the optimal choice for a given patient, it can be trial and error for a physician—they pick a medication based on their past experience or drug prescribing information in the hope that the patient’s body responds effectively to it.
- According to a recent National Institutes of Health study, pharmacogenetic testing “has the potential to decrease morbidity, decrease treatment-emergent side effects, improve treatment response, decrease inpatient admissions and readmissions due to lack of efficacy or side effects, and cost of care for the patient and his or her family.
- Shaybaarada GENETWORx waxay caddeeyeen farqigan adeegyada daryeelka caafimaadka ilaa 2013 waxayna bilaabeen inay farqigaas ku soo daraan baarista farmashiyaha ama PGx ee ka caawiya dhakhaatiirta inay helaan daawooyinka saxda ah iyo qiyaasta saxda ah markii ugu horeysay ee ku saleysan DNA-da bukaanka.
